32% of working-age Americans with private insurance carry medical debt, with harmful financial and health consequences.

Walmart's Medicare Advantage tie-up with health insurer Scan tests whether trusted retailers can influence health choices without directly providing care.

Drug pricing and TrumpRx questions eat into valuable doctor time. Drugmakers need to guide consumers to the right Rx resources.

Without upfront cost estimates and early financial guidance, patients are making tough financial trade-offs.

The healthcare cost crisis hits everyone, but especially Gen Z, making even modest steps like promoting lower-cost products and financial assistance an opportunity for healthcare players to improve their standing with strained patients.

Reduced employer coverage of weight loss drugs could push patients to cash-pay options or off treatment, increasing pressure on pharma companies to lower prices.

Healthcare membership buyers tend to skew younger, but a new GoodRx offering could tap a broader market of consumers losing coverage while still needing routine care.

Like other big health insurers, CVS is exiting unprofitable markets while trimming members—a playbook to earn Wall Street approval as patients scramble for new coverage.

Health benefits leaders often fail to inform workers about Rx savings options because opaque PBM contracts create confusion, driving the rise of more transparent, direct-to-employer pharma models.

As healthier members opt out of ACA plans, insurers will be left with sicker patients who they’ll need to push toward lower-cost care.

Drugmakers’ price drops don’t affect all patients the same. Brands and marketers must decode cost complexities where patients already seek out weight loss advice, like on social media.

Aetna is finally finding its footing, managing medical costs more effectively, even as industry-wide pressures remain.

The cash-pay discount hub will offer fewer drugs than GoodRx and have limited reach, but drugmakers must still promote it to drive prescription volumes, especially for uninsured drugs.

Benefits emerge with adherence, increasing pressure on employers to keep coverage.

News on drugmaker deals, weight loss drug coverage, medication price hikes, and health insurance to kick off the New Year.

Promoting savings via pharmacies, doctors, and online patient forums could help raise awareness of these coupons and pass on the savings needed to reduce prescription nonadherence.

Health systems and health insurers are at risk of losing business due to the new law, but have an opportunity to proactively support patients through upcoming changes to Medicaid coverage.

Pharma companies see pricing concessions as the lesser of two evils, as the price cuts grant exemption from Trump’s tariffs on US drug imports.

23% now say it’s in crisis—the highest share in 30 years—with affordability fears at the core.

Younger consumers are more likely than older generations to put off care or treatment due to cost, according to a September 2025 Pymnts survey. Younger consumers are generally healthier than older adults, which may make their medical needs feel less urgent. Provider organizations must show Gen Z why staying on top of their health matters—and that care doesn’t have to be expensive in many instances.